FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897095944> ?p ?o ?g. }

• W2897095944 endingPage "108.e12" @default.
• W2897095944 startingPage "108.e1" @default.
• W2897095944 abstract "BackgroundMaternal diabetes induces neural tube defects and stimulates the activity of the forkhead box O3 (Fox)O3a in the embryonic neuroepithelium. We previously demonstrated that deleting the FOXO3a gene ameliorates maternal diabetes-induced neural tube defects. Macroautophagy (hereafter referred to as “autophagy”) is essential for neurulation. Rescuing autophagy suppressed by maternal diabetes in the developing neuroepithelium inhibits neural tube defect formation in diabetic pregnancy. This evidence suggests a possible link between FoxO3a and impaired autophagy in diabetic embryopathy.ObjectiveWe aimed to determine whether maternal diabetes suppresses autophagy through FoxO3a, and if the transcriptional activity of FoxO3a is required for the induction of diabetic embryopathy.Study DesignWe used a well-established type 1 diabetic embryopathy mouse model, in which diabetes was induced by streptozotocin, for our in vivo studies. To determine if FoxO3a mediates the inhibitory effect of maternal diabetes on autophagy in the developing neuroepithelium, we induced diabetic embryopathy in FOXO3a gene knockout mice and FoxO3a dominant negative transgenic mice. Embryos were harvested at embryonic day 8.5 to determine FoxO3a and autophagy activity and at embryonic day 10.5 for the presence of neural tube defects. We also examined the expression of autophagy-related genes. C17.2 neural stem cells were used for in vitro examination of the potential effects of FoxO3a on autophagy.ResultsDeletion of the FOXO3a gene restored the autophagy markers, lipidation of microtubule-associated protein 1A/1B-light chain 3I to light chain 3II, in neurulation stage embryos. Maternal diabetes decreased light chain 3I-positive puncta number in the neuroepithelium, which was restored by deleting FoxO3a. Maternal diabetes also decreased the expression of positive regulators of autophagy (Unc-51 like autophagy activating kinase 1, Coiled-coil myosin-like BCL2-interacting protein, and autophagy-related gene 5) and the negative regulator of autophagy, p62. FOXO3a gene deletion abrogated the dysregulation of autophagy genes. In vitro data showed that the constitutively active form of FoxO3a mimicked high glucose in repressing autophagy. In cells cultured under high-glucose conditions, overexpression of the dominant negative FoxO3a mutant blocked autophagy impairment. Dominant negative FoxO3a overexpression in the developing neuroepithelium restored autophagy and significantly reduced maternal diabetes-induced apoptosis and neural tube defects.ConclusionOur study revealed that diabetes-induced FoxO3a activation inhibited autophagy in the embryonic neuroepithelium. We also observed that FoxO3a transcriptional activity mediated the teratogenic effect of maternal diabetes because dominant negative FoxO3a prevents maternal diabetes-induced autophagy impairment and neural tube defect formation. Our findings suggest that autophagy activators could be therapeutically effective in treating maternal diabetes-induced neural tube defects. Maternal diabetes induces neural tube defects and stimulates the activity of the forkhead box O3 (Fox)O3a in the embryonic neuroepithelium. We previously demonstrated that deleting the FOXO3a gene ameliorates maternal diabetes-induced neural tube defects. Macroautophagy (hereafter referred to as “autophagy”) is essential for neurulation. Rescuing autophagy suppressed by maternal diabetes in the developing neuroepithelium inhibits neural tube defect formation in diabetic pregnancy. This evidence suggests a possible link between FoxO3a and impaired autophagy in diabetic embryopathy. We aimed to determine whether maternal diabetes suppresses autophagy through FoxO3a, and if the transcriptional activity of FoxO3a is required for the induction of diabetic embryopathy. We used a well-established type 1 diabetic embryopathy mouse model, in which diabetes was induced by streptozotocin, for our in vivo studies. To determine if FoxO3a mediates the inhibitory effect of maternal diabetes on autophagy in the developing neuroepithelium, we induced diabetic embryopathy in FOXO3a gene knockout mice and FoxO3a dominant negative transgenic mice. Embryos were harvested at embryonic day 8.5 to determine FoxO3a and autophagy activity and at embryonic day 10.5 for the presence of neural tube defects. We also examined the expression of autophagy-related genes. C17.2 neural stem cells were used for in vitro examination of the potential effects of FoxO3a on autophagy. Deletion of the FOXO3a gene restored the autophagy markers, lipidation of microtubule-associated protein 1A/1B-light chain 3I to light chain 3II, in neurulation stage embryos. Maternal diabetes decreased light chain 3I-positive puncta number in the neuroepithelium, which was restored by deleting FoxO3a. Maternal diabetes also decreased the expression of positive regulators of autophagy (Unc-51 like autophagy activating kinase 1, Coiled-coil myosin-like BCL2-interacting protein, and autophagy-related gene 5) and the negative regulator of autophagy, p62. FOXO3a gene deletion abrogated the dysregulation of autophagy genes. In vitro data showed that the constitutively active form of FoxO3a mimicked high glucose in repressing autophagy. In cells cultured under high-glucose conditions, overexpression of the dominant negative FoxO3a mutant blocked autophagy impairment. Dominant negative FoxO3a overexpression in the developing neuroepithelium restored autophagy and significantly reduced maternal diabetes-induced apoptosis and neural tube defects. Our study revealed that diabetes-induced FoxO3a activation inhibited autophagy in the embryonic neuroepithelium. We also observed that FoxO3a transcriptional activity mediated the teratogenic effect of maternal diabetes because dominant negative FoxO3a prevents maternal diabetes-induced autophagy impairment and neural tube defect formation. Our findings suggest that autophagy activators could be therapeutically effective in treating maternal diabetes-induced neural tube defects." @default.
• W2897095944 created "2018-10-26" @default.
• W2897095944 creator A5008171524 @default.
• W2897095944 creator A5048538788 @default.
• W2897095944 creator A5053677698 @default.
• W2897095944 creator A5086297696 @default.
• W2897095944 creator A5090679738 @default.
• W2897095944 date "2019-01-01" @default.
• W2897095944 modified "2023-10-15" @default.
• W2897095944 title "The increased activity of a transcription factor inhibits autophagy in diabetic embryopathy" @default.
• W2897095944 cites W1885149309 @default.
• W2897095944 cites W1963521777 @default.
• W2897095944 cites W1968100018 @default.
• W2897095944 cites W1978641537 @default.
• W2897095944 cites W1979187096 @default.
• W2897095944 cites W1991105254 @default.
• W2897095944 cites W2007065615 @default.
• W2897095944 cites W2025155323 @default.
• W2897095944 cites W2032049429 @default.
• W2897095944 cites W2041592991 @default.
• W2897095944 cites W2046110868 @default.
• W2897095944 cites W2049431269 @default.
• W2897095944 cites W2051696465 @default.
• W2897095944 cites W2051999773 @default.
• W2897095944 cites W2061015988 @default.
• W2897095944 cites W2064997884 @default.
• W2897095944 cites W2072994145 @default.
• W2897095944 cites W2082852887 @default.
• W2897095944 cites W2088917778 @default.
• W2897095944 cites W2089472463 @default.
• W2897095944 cites W2103596595 @default.
• W2897095944 cites W2106677353 @default.
• W2897095944 cites W2124792648 @default.
• W2897095944 cites W2156563694 @default.
• W2897095944 cites W2175312664 @default.
• W2897095944 cites W2178497680 @default.
• W2897095944 cites W2277544136 @default.
• W2897095944 cites W2293304001 @default.
• W2897095944 cites W2296202983 @default.
• W2897095944 cites W2319813837 @default.
• W2897095944 cites W2563723680 @default.
• W2897095944 cites W2605702331 @default.
• W2897095944 cites W2610767031 @default.
• W2897095944 cites W2613085673 @default.
• W2897095944 cites W2716709605 @default.
• W2897095944 cites W2726825938 @default.
• W2897095944 cites W2748135641 @default.
• W2897095944 cites W2765130492 @default.
• W2897095944 cites W2781035864 @default.
• W2897095944 cites W2781952761 @default.
• W2897095944 cites W2792956190 @default.
• W2897095944 cites W2800312276 @default.
• W2897095944 doi "https://doi.org/10.1016/j.ajog.2018.10.001" @default.
• W2897095944 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6463484" @default.
• W2897095944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30312583" @default.
• W2897095944 hasPublicationYear "2019" @default.
• W2897095944 type Work @default.
• W2897095944 sameAs 2897095944 @default.
• W2897095944 citedByCount "6" @default.
• W2897095944 countsByYear W28970959442020 @default.
• W2897095944 countsByYear W28970959442021 @default.
• W2897095944 countsByYear W28970959442022 @default.
• W2897095944 countsByYear W28970959442023 @default.
• W2897095944 crossrefType "journal-article" @default.
• W2897095944 hasAuthorship W2897095944A5008171524 @default.
• W2897095944 hasAuthorship W2897095944A5048538788 @default.
• W2897095944 hasAuthorship W2897095944A5053677698 @default.
• W2897095944 hasAuthorship W2897095944A5086297696 @default.
• W2897095944 hasAuthorship W2897095944A5090679738 @default.
• W2897095944 hasBestOaLocation W28970959441 @default.
• W2897095944 hasConcept C102225024 @default.
• W2897095944 hasConcept C104317684 @default.
• W2897095944 hasConcept C126322002 @default.
• W2897095944 hasConcept C129536746 @default.
• W2897095944 hasConcept C134018914 @default.
• W2897095944 hasConcept C136834591 @default.
• W2897095944 hasConcept C145103041 @default.
• W2897095944 hasConcept C190283241 @default.
• W2897095944 hasConcept C196843134 @default.
• W2897095944 hasConcept C200707615 @default.
• W2897095944 hasConcept C203522944 @default.
• W2897095944 hasConcept C2780594696 @default.
• W2897095944 hasConcept C28328180 @default.
• W2897095944 hasConcept C54355233 @default.
• W2897095944 hasConcept C555293320 @default.
• W2897095944 hasConcept C71924100 @default.
• W2897095944 hasConcept C86803240 @default.
• W2897095944 hasConcept C87073359 @default.
• W2897095944 hasConcept C95444343 @default.
• W2897095944 hasConceptScore W2897095944C102225024 @default.
• W2897095944 hasConceptScore W2897095944C104317684 @default.
• W2897095944 hasConceptScore W2897095944C126322002 @default.
• W2897095944 hasConceptScore W2897095944C129536746 @default.
• W2897095944 hasConceptScore W2897095944C134018914 @default.
• W2897095944 hasConceptScore W2897095944C136834591 @default.
• W2897095944 hasConceptScore W2897095944C145103041 @default.
• W2897095944 hasConceptScore W2897095944C190283241 @default.
• W2897095944 hasConceptScore W2897095944C196843134 @default.

• next